These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18366761)

  • 21. Austrian report on longitudinal outcome in phenylketonuria.
    Scheibenreiter S; Tiefenthaler M; Hinteregger V; Strobl W; Mühl A; Ewald A; Schadler M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S45-9. PubMed ID: 8828608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units].
    Campistol J; González MJ; Gutiérrez AP; Vilaseca MA;
    Med Clin (Barc); 2012 Mar; 138(5):185-91. PubMed ID: 21794880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosocial aspects of PKU: hidden disabilities--a review.
    Gentile JK; Ten Hoedt AE; Bosch AM
    Mol Genet Metab; 2010; 99 Suppl 1():S64-7. PubMed ID: 20123473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
    Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
    Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria.
    Cazzorla C; Cegolon L; Burlina AP; Celato A; Massa P; Giordano L; Polo G; Daniele A; Salvatore F; Burlina AB
    BMC Public Health; 2014 Dec; 14():1243. PubMed ID: 25471331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study.
    Huijbregts SCJ; Bosch AM; Simons QA; Jahja R; Brouwers MCGJ; De Sonneville LMJ; De Vries MC; Hofstede FC; Hollak CEM; Janssen MCH; Langendonk JG; Rubio-Gozalbo ME; Van der Meere JJ; Van der Ploeg AT; Van Spronsen FJ
    Mol Genet Metab; 2018 Sep; 125(1-2):96-103. PubMed ID: 30007854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and associated factors in parents of children with late diagnosed phenylketonuria. A cross sectional study in a developing country (Tunisia).
    Ben Abdelaziz R; Ben Chehida A; Kachouri H; Ben Messaoud S; Ferchichi M; Ben Ameur Z; Sassi Y; Abdelmoula MS; Azzouz H; Tebib N
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):901-913. PubMed ID: 32639944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
    Palermo L; MacDonald A; Limback E; Robertson L; Howe S; Geberhiwot T; Romani C
    J Clin Exp Neuropsychol; 2020 Mar; 42(2):142-159. PubMed ID: 31790339
    [No Abstract]   [Full Text] [Related]  

  • 31. Transition of young adults with phenylketonuria from pediatric to adult care.
    Mütze U; Roth A; Weigel JF; Beblo S; Baerwald CG; Bührdel P; Kiess W
    J Inherit Metab Dis; 2011 Jun; 34(3):701-9. PubMed ID: 21305352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intellectual development and academic achievement of children treated early for phenylketonuria.
    Berry HK; O'Grady DJ; Perlmutter LJ; Bofinger MK
    Dev Med Child Neurol; 1979 Jun; 21(3):311-20. PubMed ID: 467815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult patient perspectives on phenylketonuria care: Highlighting the need for dedicated adult management and services.
    Suddaby JS; Sohaei D; Bell H; Tavares S; Lee GJ; Szybowska M; So J
    Eur J Med Genet; 2020 Apr; 63(4):103818. PubMed ID: 31778858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factors influencing the quality of life of 104 children with phenylketonuria in Anhui Province, China].
    Li S; Sun QL; Zhou Y; Zhang Y; Hu XJ; Hong WS; Ji GP
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Aug; 18(8):702-6. PubMed ID: 27530785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric symptoms and disorders in phenylketonuria.
    Brumm VL; Bilder D; Waisbren SE
    Mol Genet Metab; 2010; 99 Suppl 1():S59-63. PubMed ID: 20123472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial aspects in phenylketonuria.
    Weglage J; Fünders B; Ullrich K; Rupp A; Schmidt E
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S101-4. PubMed ID: 8828622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social behaviour and task orientation in early-treated PKU.
    Kalverboer AF; van der Schot LW; Hendrikx MM; Huisman J; Slijper FM; Stemerdink BA
    Acta Paediatr Suppl; 1994 Dec; 407():104-5. PubMed ID: 7766941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.